PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for ...

The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...

Gilead Sciences has agreed to buy German clinical-stage biotechnology company Tubulis for up to $5 billion in a deal that bolsters the biopharmaceutical company’s oncology pipeline.

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

ASX biotech shares are trading at valuations that lag those of the US Nasdaq index. This discrepancy won't last, experts say.

Focused on immunology therapies, this clinical-stage biotech reported significant insider selling amid a challenging year for ...

With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has ...

Gilead is buying the German biotech Tubulis for more than $3 billion, a move that will expand its oncology pipeline.

Integrated consulting approach streamlines pathway from concept to commercialization NEW YORK, NY, UNITED STATES, April ...

Tetra Pak and Lund University launch Biotech Heights, a hub for food and material biotechnology, enabling start-ups and researchers to collaborate on sustainable solutions.

The FDA is expected to make its decision on Priovant's application for brepocitinib in the third quarter. The health care ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...